Shiv Cancer Institute Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 31-07-2024
- Paid Up Capital ₹ 2.00 Cr
as on 31-07-2024
- Company Age 10 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.13 Cr
as on 31-07-2024
- Satisfied Charges ₹ 8.76 Cr
as on 31-07-2024
- Revenue 33.65%
(FY 2023)
- Profit 373.44%
(FY 2023)
- Ebitda 65.69%
(FY 2023)
- Net Worth 21.37%
(FY 2023)
- Total Assets 7.32%
(FY 2023)
About Shiv Cancer Institute
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹1.13 Cr. The company has closed loans amounting to ₹8.76 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sharad Desai and Leela Desai serve as directors at the Company.
- CIN/LLPIN
U85100PN2014PTC150127
- Company No.
150127
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jan 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Miraj, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Shiv Cancer Institute?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sharad Desai  | Director | 10-Jan-2014 | Current |
| Leela Desai | Director | 10-Jan-2014 | Current |
Financial Performance of Shiv Cancer Institute.
Shiv Cancer Institute Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 33.65% increase. The company also saw a substantial improvement in profitability, with a 373.44% increase in profit. The company's net worth Soared by an impressive increase of 21.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shiv Cancer Institute?
In 2023, Shiv Cancer Institute had a promoter holding of 56.08% and a public holding of 43.93%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shiv Cancer Center Private LimitedActive 3 years 2 monthsSharad Desai and Leela Desai are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Shri Veershaiv Co-Op Bank Ltd Creation Date: 02 Jul 2015 | ₹1.13 Cr | Open |
Tjsb Sahakari Bank Limited Creation Date: 18 Feb 2017 | ₹6.45 M | Satisfied |
Tjsb Sahakari Bank Limited Creation Date: 07 Dec 2015 | ₹1.22 M | Satisfied |
How Many Employees Work at Shiv Cancer Institute?
Unlock and access historical data on people associated with Shiv Cancer Institute, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shiv Cancer Institute, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shiv Cancer Institute's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
